Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines
Educational Objectives:
Faculty:
James Lewis, PharmD, FIDSA
ID Clinical Pharmacy Supervisor
Oregon Health & Sciences University
Portland, Oregon
James Lewis, PharmD, FIDSA, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022.
This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.